A lack of assurance of sterility has prompted Imprimis NJOF to voluntarily recall 4280 boxes of compounded prednisolone acetate 1%, moxifloxacin 0.5%, and bromfenac 0.075% ophthalmic suspension.
A lack of assurance of sterility has prompted Imprimis NJOF to voluntarily recall 4280 boxes of compounded prednisolone acetate 1%, moxifloxacin 0.5%, and bromfenac 0.075% ophthalmic suspension.
A lack of assurance of sterility...